In the previously reported ENU screen [5] , viable F5 L/L Tfpi +/rescue mice were 1 0 5 outcrossed to the 129S1/SvImJ strain to introduce the genetic diversity required for 1 0 6 subsequent mapping experiments. However, complex strain modifier gene interactions 1 0 7 confounded this analysis and resulted in a large number of "phenocopies" (defined as 1 0 8 viable F5 L/L Tfpi +/mice lacking the original rescue mutation). To eliminate confounding 1 0 9 effects of these thrombosis strain modifiers, we generated an additional 2,834 G1 1 1 0 offspring exclusively maintained on the C57BL/6J background. Fifteen new rescue 1 1 1 pedigrees were established from this screen (S1 Table) . The frequency, survival, 1 1 2 6 weight, and sex distributions of identified rescues were consistent with our previous 1 1 3 report (S1 Fig) . Though many of the pedigrees previously generated on the mixed 1 1 4 129S1/SvImJ-C57BL/6J background generated >45 rescue progeny per pedigree (8/16) 1 1 5 [5] , all pedigrees on the pure C57BL/6J background yielded <36 rescue mice (most 1 1 6 generating ≤ 5 rescues) (S1 Table) . Significantly smaller pedigrees in comparison to the C57BL/6J and 129S1/SvImJ strains have been shown to exhibit significant differences 1 2 1 in a number of hemostasis-related parameters, including platelet count and TFPI and 1 2 2 tissue factor expression levels [12] , with the genetic variations underlying such strain 1 2 3 specific differences likely contributing to the genetic mapping complexity noted in the 1 2 4 previous report [5] . 1 2 5 1 2 6 Linkage analysis using coding ENU variants fails to map suppressor loci 1 2 7
As the rescue pedigrees were maintained on a pure C57BL/6J background, the 1 2 8 only genetic markers that could be used for mapping were ENU-induced variants. WES 1 2 9 of one G1 or G2 member of the three largest pedigrees (1, 6, and 13, S2 Table) , 1 3 0 identified a total of 86 candidate ENU variants that were also validated by Sanger 1 3 1 1 4 2 from a non-ENU-induced variant [13] or an unexpectedly high phenocopy rate. While 1 4 3 WES has been successfully applied to identify causal ENU variants within inbred lines 1 4 4 [14] and in mixed background lines [15, 16] , whole genome sequencing (WGS) provides 1 4 5 much denser and more even coverage of the entire genome (~3,000 ENU 1 4 6 variants/genome expected) and outperforms WES for mapping [11] . However, a WGS 1 4 7 approach requires sequencing multiple pedigree members [10] , or pooled samples at 1 4 8 being targeted by chance. Probability distributions were obtained by running 10 million 3 7 7 random permutations using probabilities adjusted to the length of the protein coding 3 7 8 region. A detailed pipeline for the permutation analysis is available online 3 7 9 (github.com/tombergk/FVL_mod). Genes that harbored more potentially damaging 3 8 0 ENU-induced variants than expected by chance were considered as candidate modifier 3 8 1 genes. FDR statistical correction for multiple testing was applied as previously All coding variants in pedigrees 1, 6, and 13 as well as all variants in candidate 3 8 6 modifier genes from the burden analysis were assessed using Sanger sequencing.
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Variants were considered ENU-induced if identified in the G1 rescue but not its parents.
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All primers were designed using Primer3 software [38] and purchased from Integrated 3 8 9 DNA Technologies. PCR was performed using GoTaq Green PCR Master Mix 3 9 0 (Promega), visualized on 2% agarose gel, and purified using QIAquick Gel Extraction 3 9 1 Kit (Qiagen). Sanger sequencing of purified PCR products was performed by the 3 9 2
University of Michigan Sequencing Core. Outer primers were used to generate the PCR 3 9 3 product which was then sequenced using the internal sequencing primers. All outer 3 9 4 PCR primers (named: gene name+'_OF/OR') and internal sequencing primers (named: 3 9 5 gene name+'_IF/IR') are listed in S9 Table. 3 9 6 3 9 7
Guide RNA design and in vitro transcription 3 9 8
Guide RNA target sequences were designed with computational tools [39, 40] 3 9 9 (http://www.broadinstitute.org/rnai/public/analysis-tools/sgrna-design or http://genome-4 0 0 engineering.org) and top predictions per each candidate gene were selected for 4 0 1 functional testing (S10 Table) guide Cpn1-g2 targeting Cpn1 (S10 Table) . The mixture of sgRNAs, Cas9 mRNA, and Initially, sgRNA targeted loci were tested using PCR and Sanger sequencing 4 5 4 (primer sequences provided in S10 Table) . Small INDELs were deconvoluted from 4 5 5
Sanger sequencing reads using TIDE software [45] . A selection of null alleles from >190 4 5 6 editing events were maintained for validation (S5 Table) . Large (>30 bp) deletions were 4 5 7 genotyped using PCR reactions that resulted in two visibly distinct PCR product sizes 4 5 8
for the deletion and wildtype alleles. Expected product sizes and genotyping primers for 4 5 9 each deletion are listed in S5 
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Primer pairs were designed for each gene using Primer Express 3.0 software (S9 4 6 8 A) The ENU screen strategy is depicted here, along with the total numbers of G1 5 3 7 offspring observed by genotype. B) Survival curves for G1 rescue mice. Approximately 5 3 8 50% of the rescue mice died by 6 weeks of age, with no significant survival difference 5 3 9 observed between females and males (p=0.077), though females were 5 4 0 underrepresented compared to males during the initial genotyping (28 females 5 4 1 compared to 48 males, p=0.022). C-D) Weight at genotyping (at 14-21 days) was on 5 4 2 average 25-30% smaller for G1 rescues than their littermates (p=7x10 -13 ). E) Survival of 5 4 3 rescue mice beyond G1 (≥G2) is also reduced, with worse outcome in females 5 4 4 2 5 (p=0.002). Across all pedigrees, mice beyond G1 (≥G2) continued to exhibit reduced 5 4 5 survival with more pronounced underrepresentation of females (p=0.002), and F) an 5 4 6 average ~22% lower body weight compared to littermates (mean defined as 100%) at 5 4 7 the time of genotyping (p=2x10 -16 ). i  e  d  e  r  M  J  ,  G  r  e  e  n  G  E  ,  P  a  r  k  S  S  ,  S  t  a  m  p  e  r  B  D  ,  G  o  r  d  o  n  C  T  ,  J  o  h  n  s  o  n  J  M  ,  e  t  a  l  .  A  h  u  m  a  n  7  0  4   h  o  m  e  o  t  i  c  t  r  a  n  s  f  o  r  m  a  t  i  o  n  r  e  s  u  l  t  i  n  g  f  r  o  m  m  u  t  a  t  i  o  n  s  i  n  P  L  C  B  4  a  n  d  G  N  A  I  3  c  a  u  s  e  s  7  0 
